Mannkind (MNKD) Stock Price
$5.57 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
4 -
Technical
6
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Mannkind, AI stock picks, stock alerts and much more.
MNKD AI Stock Analysis
AI stock analysis for MNKD is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Mannkind (MNKD) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Mannkind (MNKD) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Mannkind (MNKD), currently trading at $5.57, will... Sign up to access price prediction.
About MNKD
-
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States.
-
Symbol
MNKD
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
1.7B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$19.97 1.4% |
8 |
 |
Inovio Pharmaceuticals INO |
$2.38 10.2% |
2 |
 |
Moderna MRNA |
$23.51 7.4% |
4 |
 |
Anavex Life Sciences AVXL |
$9.37 2.2% |
5 |
 |
BridgeBio Pharma BBIO |
$51.21 2.6% |
6 |
News
MNKD Alternative Data
Web Traffic
Mannkind receives an estimated 16874 monthly visitors to mannkindcorp.com, which is up by 38% over the last month.
-
Web Traffic
16874
-
Change from Previous Month
38%
-
3 Month Change
101.3%
-
YoY Change
101.3%
Twitter Followers
Mannkind has 2,786 Twitter Followers on its main Twitter (also known as X) account, which is down by -0% over the last month.
-
Twitter Followers
2786
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.5%
-
YoY Change
0.5%
Facebook Engagement
Mannkind has engaged 19 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
19
-
Daily Change
11.8%
-
1 Month Change
47.2%
-
3 Month Change
66.1%
-
YoY Change
66.1%
Instagram Followers
Mannkind has 1,262 Instagram Followers on its main Instagram account, up by 1% over the last month.
-
Instagram Followers
1262
-
Daily Change
0%
-
1 Month Change
1%
-
3 Month Change
4.8%
-
YoY Change
4.8%
Youtube Subscribers
Mannkind has 271 subscribers on its main Youtube channel.
-
Youtube Subscribers
271
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.4%
-
YoY Change
0.4%
LinkedIn Followers
16,458 are following Mannkind on LinkedIn, up by 5.6% over the last month.
-
LinkedIn Followers
16458
-
Daily Change
0%
-
1 Month Change
5.6%
-
3 Month Change
11.8%
-
YoY Change
11.8%
Job Postings
Mannkind has an estimated 55 open job postings, which is down -1.8% over the last month.
-
Job Postings
55
-
Daily Change
0%
-
1 Month Change
1.8%
-
3 Month Change
129.2%
-
YoY Change
129.2%
LinkedIn Employees
According to LinkedIn, Mannkind has 606 employees, down by -1% over the last month.
-
LinkedIn Employees
606
-
Daily Change
0.2%
-
1 Month Change
1%
-
3 Month Change
2.2%
-
YoY Change
2.2%
Reddit Mentions
Mannkind has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Mannkind is 83 out of 100 (very bullish).
-
Business Outlook
83
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Mannkind was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
MNKD Financials
MNKD Key Metrics
-
Total Revenue
$76.8M
-
Net Income
$7.4M
-
Earnings per Share
$0.027
-
Free cash flow
$19.7M
-
EBITDA
$18.6M
-
EBITDA Ratio
0.242446
-
Total Assets
$393.8M
MNKD 2-year Revenue & Income
MNKD 2-year Free Cash Flow
MNKD Technicals
MNKD SMA
MNKD RSI
FAQ
What's the current price of Mannkind (MNKD) Stock?
The price of an Mannkind (MNKD) share is $5.57.
What's the market cap of Mannkind?
The current market cap of Mannkind is 1.7B.
What are some stocks similar to Mannkind (MNKD) that investors often compare it to?
Mannkind (MNKD) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Mannkind's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Mannkind's stock price to be around $5.95 in 2026. Starting from the current price of $5.57, this represents a 6.8% change in price, indicating a bullish outlook for the stock.
How to buy Mannkind (MNKD) Stock?
Mannkind stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Mannkind shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.